Human metabolism and excretion kinetics of benzotriazole UV stabilizer UV-327 after single oral administration.

Journal Information

Full Title: Arch Toxicol

Abbreviation: Arch Toxicol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Toxicology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of interestE. Leibold is employed by BASF SE, a former manufacturer of UV-327; however, BASF SE was not involved in the study design nor in the evaluation or interpretation of the results. C. Fischer, J. Hiller, and T. Göen have no conflicts of interest to declare. Ethics approvalThe study has been approved by the ethics committee of the medical faculty of Friedrich-Alexander-Universität Erlangen-Nürnberg (49_18 B) and has been performed in accordance with all relevant ethical standards. All study participants gave their written and informed consent to participate in the study. Conflict of interest E. Leibold is employed by BASF SE, a former manufacturer of UV-327; however, BASF SE was not involved in the study design nor in the evaluation or interpretation of the results. C. Fischer, J. Hiller, and T. Göen have no conflicts of interest to declare."

Evidence found in paper:

"Funding Open Access funding enabled and organized by Projekt DEAL. Method development was financed by Chemie Wirtschaftsförderungsgesellschaft mbH."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025